The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

[7] Among men with both DO and BOO that did not improve on alpha-blocker monotherapy, 73% did show symptomatic improvement after 3 months of tolterodine treatment. Urge urinary incontinence ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

((SL Advertiser)) V-Juv offers up a simple solution for men and women who suffer from incontinence. No more diapers! call ...

When an overactive bladder is affecting your daily life, this might be just the time to look into treatment options. I'm Joy Behar. And I'm talking with an expert on OAB about how to solve this ...

WebMD tells you about the causes and treatments of urinary incontinence in men. What Your Pee Can Tell You About Your Health Your pee -- you see it every day, and you might not think twice about it.

OAB can significantly impact quality of life; it can impact physical functioning, sexual function and social interactions. The standard treatments for overactive bladder include lifestyle changes ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

Treatment with vibegron reduced the ... approval of Gemtesa is an important milestone for the men with unresolved symptoms of OAB while being treated for BPH, which underscores our urgency to ...